Bacterial cell wall peptidoglycan precursor

The **bacterial cell wall peptidoglycan precursor** refers to a series of specialized biochemical intermediates—such as UDP-N-acetylmuramyl-pentapeptide, Lipid I, and Lipid II—that are essential for constructing the peptidoglycan layer of the bacterial cell wall[3][7][10]. Peptidoglycan is a mesh-like polymer made of alternating N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc) sugars, with short peptide chains cross-linking the glycan strands. Precursor molecules are synthesized in the cytoplasm, combined with a lipid carrier (undecaprenyl phosphate) in the membrane (producing Lipid I and then Lipid II), and finally transported to the periplasmic space where they are polymerized and cross-linked to form the mature cell wall[2][3][7]. Targeting these precursors or the enzymes that process them is the main mode of action for many major classes of antibiotics, such as β-lactams (penicillins, cephalosporins), glycopeptides (vancomycin), fosfomycin, and others[7][9]. Since humans lack peptidoglycan and its precursors, drugs that block peptidoglycan precursor synthesis display high specificity for bacteria, making this pathway a critical and validated therapeutic target[7]. Caveats/limitations: - This target is a class of chemical intermediates, not a single isolated protein or enzyme. It serves as a validated and essential point of attack for antimicrobials but is not itself a biological macromolecule such as a typical enzyme or receptor. - Some antibiotics interact with enzymes that process the precursors rather than binding directly to the precursor molecule itself[7].

Other names

Peptidoglycan precursorPeptidoglycan biosynthesis intermediateLipid IIUDP-MurNAc-pentapeptidePeptidoglycan monomer

Inhibition of cell wall synthesis (by blocking transpeptidation or glycosyltransferase activity); Inhibiting precursor formation (e.g., fosfomycin inhibits MurA; D-cycloserine inhibits D-Ala-D-Ala ligase); Inhibiting lipid carrier recycling (e.g., bacitracin); Preventing cross-linking of peptidoglycan strands (e.g., β-lactams target penicillin-binding proteins; vancomycin binds D-Ala-D-Ala terminus)